ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Tocilizumab in Lung Transplantation

ClinicalTrials.gov ID: NCT06033196

Public ClinicalTrials.gov record NCT06033196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 7:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Tocilizumab (CTOT-45)

Study identification

NCT ID
NCT06033196
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
350 participants

Conditions and interventions

Interventions

  • Placebo for Tocilizumab Drug
  • Tocilizumab Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 12, 2024
Primary completion
Jan 7, 2029
Completion
Jan 7, 2029
Last update posted
Mar 26, 2026

2024 – 2029

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
St. Joseph's Hospital and Medical Center (Site #: 71192) Phoenix Arizona 85013 Recruiting
Cedars Sinai Medical Center (Site #: 71146) Beverly Hills California 90211 Recruiting
David Geffen School of Medicine at UCLA (Site #: 71123) Los Angeles California 90095 Recruiting
University of Florida Shands Hospital (Site #: 71131) Gainesville Florida 32610 Not yet recruiting
Emory University (Site #: 71103) Atlanta Georgia 55905 Not yet recruiting
University of Maryland Medical Center (Site #: 71138) Baltimore Maryland 21201 Withdrawn
Massachusetts General Hospital (Site #: 71107) Boston Massachusetts 02114 Recruiting
Boston Children's Hospital and Harvard Medical School (Site #: 71001) Boston Massachusetts 02215 Withdrawn
Mayo Clinic Rochester (Site #: 71160) Rochester Minnesota 55905 Not yet recruiting
Barnes Jewish Hospital/ Washington University SOM (Site #: 71191) St Louis Missouri 63110 Recruiting
St. Louis Children's Hospital of Washington University (Site #: 71006) St Louis Missouri 63110 Withdrawn
Columbia University Medical Center (Site #: 71113) New York New York 10032 Recruiting
Duke University Medical Center (Site #: 71139) Durham North Carolina 27710 Recruiting
Cleveland Clinic (Site #: 71101) Cleveland Ohio 44195 Recruiting
Ohio State University Medical Center (Site #: 71196) Columbus Ohio 43210 Not yet recruiting
Temple University (Site #: 71197) Philadelphia Pennsylvania 19140 Not yet recruiting
Vanderbilt University (Site #: 71174) Nashville Tennessee 37232-0393 Not yet recruiting
University of Texas Southwestern (Site #: 71187) Dallas Texas 75390 Recruiting
Houston Methodist Hospital (Site #: 71120) Houston Texas 77030 Withdrawn
University of Texas Health Science at San Antonio (Site #: 71198) San Antonio Texas 78229 Not yet recruiting
University of Utah Medical Center (Site #: 71126) Salt Lake City Utah 84132 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06033196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06033196 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →